Fact CheckerSign in

NCT07107022Recruiting

Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).

i-RISE: International Acute Ischemic Stroke Study With the Penumbra System®

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
30 Jul 2025
Start date
1 Nov 2025
Primary completion date
Jan 2028
Lead sponsor
Penumbra Inc.
Diseases
Stroke
NCT number
NCT07107022

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 1 Nov 2025 to the primary completion date, Jan 2028
  • 12 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • E.3. Currently participating in an investigational (drug, device, etc.) clinical trial that will influence the endovascular procedure or acute treatment of the patient. Patients in secondary prevention, observational, natural history, and/or

Other illness

  • E.1. Alberta Stroke Program Early CT Score (ASPECTS) ≤6 (for anterior circulation strokes)
  • E.2. Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days
  • E.4. Other medical, behavioral, or psychological conditions that in the opinion of the Investigator could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study

Other

  • epidemiological studies are eligible.

Who the study is looking for

  • I.1. Patient age 18-80 years
  • I.2. Pre-stroke mRS 0-1
  • I.3. Patients experiencing acute ischemic stroke who are eligible for mechanical thrombectomy using the Penumbra System
  • I.4. Frontline treatment with Penumbra System
  • I.5. Signed informed consent per Institution Review Board/Ethics Committee

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sir Charles Gairdner Hospital
Coordinator of this site? Confirm its status
NedlandsAustraliaRecruiting
Kelowna General Hospital
Coordinator of this site? Confirm its status
KelownaCanadaRecruiting
Toronto Western Hospital
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
Universitätsspital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting
Inselspital Universitätsklinik für Neurologie
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting
Universitätsklinikum Augsburg
Coordinator of this site? Confirm its status
AugsburgGermanyRecruiting
Universitätsklinikum Schleswig-Holstein (UKSH) Lübeck
Coordinator of this site? Confirm its status
LübeckGermanyRecruiting
TUM Klinikum rechts der Isar
Coordinator of this site? Confirm its status
MünchenGermanyRecruiting
Knappschaft Kliniken Vest Recklinghausen
Coordinator of this site? Confirm its status
RecklinghausenGermanyRecruiting
CHU de Bordeaux - Hôpital Pellegrin
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting
CHU de Brest - Hopital de la Cavale Blanche
Coordinator of this site? Confirm its status
BrestFranceRecruiting
Hopital Pierre Paul Riquet
Coordinator of this site? Confirm its status
ToulouseFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.